
Press Release April 01, 2025
All Provinces and Territories Sign Rare Disease Drug Agreements
Ottawa, April 1, 2025 – Quebec signed a bilateral agreement under the federal government’s National Strategy for Drugs for Rare […]
Our news library that includes all press releases and industry related news.
Press Release April 01, 2025
Ottawa, April 1, 2025 – Quebec signed a bilateral agreement under the federal government’s National Strategy for Drugs for Rare […]
Statements March 27, 2025
Industry Association Applauds Commitment to the Stratégie Québécoise des sciences de la vie (2025-2028) and to Pharmaceuticals in Hospital Settings […]
March 21, 2025
Ottawa, le 21 mars 2025. – Avec l’annonce imminente d’élections fédérales, les Canadiens ont l’occasion de réfléchir à l’avenir de leur système de […]
Press Release March 21, 2025
Ottawa, March 21, 2025 – With the imminent announcement of a federal election, Canadians have an opportunity to reflect on the […]
Statements February 03, 2025
Ottawa, February 3, 2025 – Innovative Medicines Canada (IMC) is pleased to welcome Patrick Hupé, M.Sc., MBA, as Vice President […]
Statements December 16, 2024
Ottawa, December 16, 2024 – Following the release of the Fall Economic Statement, Innovative Medicines Canada (IMC) is calling on […]
Press Release December 16, 2024
Toronto, December 16, 2024 – Innovative Medicines Canada (IMC) welcomes the collective agreement amongst Canada’s Premiers to take meaningful action […]
Press Release November 19, 2024
CAMZYOS™ RECOGNIZED FOR THE TREATMENT OF obstructive hypertrophic cardiomyopathy Ottawa, November 19, 2024 – Prix Galien Canada is pleased to […]
Press Release November 19, 2024
DR. MICHAEL HILL WINS THE MEDAL OF HONOUR, DR. SONIA ANAND WINS THE DIVERSITY AND EQUITY IN RESEARCH AWARD Ottawa, […]
Statements November 15, 2024
We are disappointed to see that, once again, the government has excluded the pharmaceutical industry’s voice from important discussions on […]
Statements October 15, 2024
Today’s announcement by the Ontario government of a $146 million investment in the next phase of the Life Sciences Strategy […]
Statements October 11, 2024
With the passage of the Pharmacare Act, Innovative Medicines Canada remains concerned that the pharmacare program as outlined in the […]
Informative content to keep you up to date on the most pressing issues facing our industry.